Cardiomyocyte death is the chief obstacle that prevents the heart function recovery in myocardial infarction (MI)-induced heart failure (HF). Cardiac progenitor cells (CPCs)-based myocardial regeneration has provided a promising method for heart function recovery after MI. However, CPCs can easily lose their proliferation ability due to oxygen deficiency in infarcted myocardium. Revealing the underlying molecular mechanism for CPC proliferation is critical for effective MI therapy. In the present study, we set up a CoCl 2 -induced hypoxia model in CPCs. We found that the expression of long noncoding RNA H19 was significantly down-regulated in CPCs after hypoxia stimuli. In addition, H19 suppression attenuated the proliferation and migration of CPCs under hypoxia stress. Furthermore, we discovered that H19 regulated the proliferation and migration of CPCs through mediating the expression of Sirt1 which is a target of miR-200a-3p under hypoxia. In conclusion, our findings demonstrate a novel regulatory mechanism for the proliferation and migration of CPCs under hypoxia condition, which provides useful information for the development of new therapeutic targets for MI therapy.
Introduction
Heart failure (HF) is the main cause of morbidity and mortality worldwide. HF induced by myocardial infarction (MI) is usually accompanied by dramatic loss of cardiomyocytes and increased amount of fibroblasts [1, 2] . Traditional therapies, such as arterial bypass technology as well as thrombolytic agents, cannot replace heart scarring with functional contractile cardiac tissue, so the mortality rate for patients who have HF induced by acute MI is still not optimistic. Recently, stem cells have offered a promising method for the heart function recovery after ischemic injury [3] [4] [5] .
Cardiac progenitor cells (CPCs) are defined as heart stem cells which are isolated from heart tissue [6] . CPCs are clustered in the interstitial microdomains which are connected with the supporting cells, such as cardiomyocytes and fibroblasts [6, 7] . In multiple animal studies, CPCs were reported to have strong regenerative ability in infarcted myocardium after transplantation [8] [9] [10] [11] [12] . CPCs were also demonstrated to alleviate myocardial dysfunction through decreasing infarct size and improving heart function by forming new functional and contracting heart tissue in the infarcted myocardium region [11, 12] . However, the CPCs can easily lose their proliferation and differentiation ability due to deficiency of oxygen and nutrients [13] . It has been reported that 40% of resident CPCs are depleted in just 1 day after MI [14] . In CPCs ex vivo expansion, only a small number of CPCs are retained after transplantation in the ischemic myocardium. Therefore, exploring the molecular mechanism for CPC proliferation and retention is important for developing effective therapy for HF induced by MI.
Long non-coding RNAs (LncRNAs) are transcribed RNA molecules which are longer than 200 nucleotides [15] [16] [17] . LncRNAs account for a large proportion of the non-coding transcriptsome which were previously ignored by researchers [15, 16] . Recently, lncRNA are emerging as an important regulator which is involved in many cellular processes, such as cell proliferation, migration, and apoptosis [15, 17] . The contributions of lncRNAs have mostly been focused on cancer and neurological disease [18] [19] [20] . In recent years, increasing evidence has suggested that lncRNAs also play important roles in the regulation of heart function [21] [22] [23] [24] . LncRNA H19 is one of the imprinted genes, which was discovered by genetic screens [25] [26] [27] . It is expressed in human and mouse developing embryos, adult skeletal muscles, and heart muscles [28, 29] . It has been demonstrated that H19 is up-regulated in pathological cardiac remodeling, suggesting its important role in maintaining heart function [30] . H19 can inhibit the cardiomyocytes hypertrophy and is a negative regulator of heart hypertrophy [31] . However, whether H19 contributes to CPC proliferation to promote heart repair is rarely reported.
In this study, we demonstrated that H19 regulates CPC proliferation and migration through the H19/miR-200a-3p/Sirt1 pathway, which opens up an opportunity for the development of novel therapeutic targets for myocardium repair after MI.
Methods and Materials

Isolation of CPCs
All the procedures were performed under sterile conditions. Briefly, the heart was removed from the C57BL/6 mice and then chopped into small pieces in cold Hanks Balance Salts solution (HBBS; Sigma, St Louis, USA). After that, collagenase (1 mg/ml in HBSS; Sigma) was used to digest the small pieces of heart tissue at 37°C for 30 min. Then the digested small pieces of heart tissue were cultured in DMEM culture medium (Gibco, Carlsbad, USA) in Matrigel-coated 6-well plate (Coring Co., Corning, USA). After 2 weeks of culture, fibroblast-like cells were migrated out and aggregated around the small pieces of heart tissue. Some 'small, round, and bright' cells were on the surface of the fibroblast-like cells. Then, these 'small, round, and bright' cells were digested with accutase (Sigma) and cultured in DMEM culture medium (Gibco). These 'small, round, and bright' cells had the required c-Kit positive CPCs. For further purification of the c-Kit positive CPCs, the 'small, round, and bright' cells were resuspended with the c-Kit (Santa Cruz Biotech, Santa Cruz, USA)-coated beads (Thermo Fisher Scientific, Waltham, USA) in the culture medium, and then incubated for 2 h at 37°C. A magnetic sorter was used to concentrate the c-Kit-coated beads. Then the c-Kit-coated beads were resuspended in the DMEM culture medium (Gibco) and cultured at 37°C and 5% CO 2 in a humidified cell incubator. After 2-3 weeks, the colonies of c-Kit positive CPCs were obtained. For further expansion of the CPCs, 0.1% trypsin (Gibco) was used to digest the CPCs, and the CPCs were plated in the 6-well plate at a concentration of 1 × 10 5 cells/ml in the culture medium.
Identification of CPCs
The purity of the CPCs was identified by flow cytometry. Briefly, the CPCs were harvested at the certain time points with different treatments. After being stained with anti-c-Kit antibody (Abcam, Cambridge, UK), anti-CD45 antibody (Abcam) and anti-CD34 antibody (Abcam) and the corresponding fluorescence-conjugated secondary antibodies (Abcam), the CPCs were analyzed with a flow cytometer equipped with CellQuest software (BD Biosciences, Franklin Lakes, USA).
Hypoxia CPC model
The procedure of hypoxia CPC model was performed as previous report [32] . In brief, the CPCs were treated with CoCl 2 at the concentrations of 100, 200, or 400 μM for 2 h at 37°C and 5% CO 2 in a humidified cell incubator. Then the CPCs were cultured with culture medium without CoCl 2 at 37°C and 5% CO 2 in a humidified cell incubator.
RNA interference and cell transfection
H19 and Sirt1 specific RNAi oligonucleotides (siRNA) were designed and synthesized by GenePharma (Shanghai, China). MiR-200a mimics and inhibitors were purchased from RiboBio (Guangzhou, China). The sequences of siRNAs were as follows: siH19-1: 5′-CCAACAUC AAAGACACCAUTT-3′; siH19-2: 5′-UAAGUCAUUUGCACUGG UUTT-3′; siH19-3: 5′-GCCCGGGCTAGGACCGAGG-3′. siSirt1-1: 5′-CCAAGCAGCUAAGAGUAAUTT-3′; siSirt1-2: 5′-GAAGUUGA CCUCCUCAUUGUdTdT-3′; siSirt1-3: 5′-GCGGGAATCCAAAGGA TAA-3′; negative control siRNA: 5′-TUACUGAUGTUUAUUCGA UGA-3′; miR-200a mimics: 5′-UAACACUGUCUGGUAACGAUG U-3′; and miR-200a inhibitor: 5′-ACAUCGUUACCAGACAGUG UUA-3′. The RNA oligonucleotides were transfected into CPCs using Lipofectamine 2000 (Invitrogen, Carlsbad, USA) in Opti-MEM culture medium. After 48 h of culture, the samples were collected for subsequent analyses.
Total RNA isolation and quantitative real-time reverse transcription-PCR Total RNA of the cells with different treatments was isolated using Trizol reagent (Invitrogen) according to the manufacturer's protocol. The RNA concentrations were detected with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific). Reverse transcription (RT) were performed using the EasyScript One-Step gDNA Removal and cDNA Synthesis SuperMix (Transgen Biotech, Shanghai, China). Real-time RT-PCR amplification was performed with 10 ng of cDNA using the SYBR Green reagent (Thermo Fisher Scientific) on the Prism 7500 SDS systerm (Applied Biosystems, Foster City, USA). Relative mRNA and microRNA expression levels were normalized to GAPDH or U6 snoRNA. The primers for various genes were as follows: H19 forward: 5′-TGCTGCACTTTACAACCACTG-3′, reverse: 5′-ATGGTGTCTTTGATGTTGGGC-3′; Hif-1α forward: 5′-CCAG TTACGTTCCTTCGATCAGT-3′, reverse: 5′-TTTGAGGACTTGC GCTTTCA-3′; miR-200a-3p forward: 5′-CCTACGCCACAATTAA CAAGCC-3′, reverse: 5′-GCCGTCTAACACTGTCTGGTA-3′; and Sirt1 forward: 5′-CAGCAAGGCGAGCATAAA-3′, reverse: 5′-TTC AGAACCACCAAAGCG-3′.
Western blot analysis
The cells samples with different treatments were lysed using RIPA lysis buffer (Thermo Fisher Scientific). Whole-cell lysates from CPCs with different treatments were subject to SDS-PAGE using 12% polyacrylamide gels. Proteins were then transferred to the Pure Nitrocellulose Blotting membrane (Millipore, Billerica, USA). The membranes were incubated with anti-Sirt1 antibody (Ab32441, 1:2000 dilution; Abcam) at 4°C overnight, followed by three times of wash with PBS (10 min each). After that, the membranes were incubated with horseradish peroxidase (HRP)-conjugated secondary antibody (1:2000 dilution; Thermo Fisher Scientific) at room temperature for 1 h and then washed with PBS for three times (10 min each). The immunoreactivity was visualized using the Chemiluminescence Detection Kit (Donghuan Biotech, Shanghai, China) and the data were analyzed using Gel-pro Analyzer Software. GAPDH was used as the loading control.
Luciferase reporter assay
The wild-type reporter construct was obtained by cloning the H19 full length or Sirt1 3′UTR sequences which were amplified by PCR technique into the psiCHECK-2 luciferase reporter plasmid (Promega, Madison, USA). The putative binding site was mutated as H19-Mut and Sirt1-Mut. In brief, HEK293T cells (Cobioer, Najing, China) were co-transfected with the H19 and Sirt1 Wt or Mut 3′-UTR reporter plasmids (2 μg), and miR-200a-3p mimic (50 nM). Forty-eight hours after transfection, luciferase activities were examined using the Dual-Luciferase Reporter Assay System (Promega).
Cell viability assay
The viability of CPCs was detected using Cell Counting kit-8 (Donghuan Biotech) following the manufacturer's instructions. Briefly, the CPCs with different treatments were seeded in a 96-well plate. Then the CCK-8 solution (10% of the medium, 10 μl) was added to each well and incubated for 4 h. Then the absorbance at 450 nm was measured using a microplate reader. Data were shown as the cell number change relative to the control.
Cell migration assay
The migration ability of CPCs was analyzed with transwell chambers (Coring Co) according to the manufacturer's introduction. Briefly, CPCs with different treatments were added in the upper transwell chamber containing medium supplemented with 0.5% FBS, while the lower chamber was filled with medium containing 10% FBS. After being cultured for 18 h, we first removed the unmigrated cells, then wash the CPCs with PBS and then stained with crystal violet for 15 min at room temperature. After the samples were air-dried, the cells in the transwell chambers was observed and imaged under a microscope (Olympus, Tokyo, Japan).
EdU incorporation assay
The CPCs were seeded in 24-well tissue culture plates at a density of 1500 cells per well. Next, 5-ethynyl-2′-deoxyuridine (EdU; Donghuan Biotech) was added to each well and incubated for 2 h after hypoxia treatment. Then the cells were fixed with 4% paraformaldehyde for 30 min at room temperature, followed by incubation with Apollo Staining reaction liquid (RiboBio, Guangzhou, China) to detect the positive cells. Hoechst (Sigma) was used for nuclear staining.
Immunofluorescence was detected by fluorescence microscopy (Zeiss, Oberkochen, Germany).
Statistical analysis
All experiments were performed at least three times. Data were analyzed by the statistical software SPSS (version 13.0.0). All data are presented as the mean ± SEM. Statistical analysis was performed using two-tailed Student's t-test or one-way ANOVA. Results were considered statistically significant at P < 0.05, while a highly significant difference at P < 0.01.
Results
Hypoxia inhibits the proliferation and migration of CPCs
The c-Kit positive CPCs were identified by expression of c-Kit which is the receptor for stem cells. However, c-Kit is also expressed by leukocytes cells. Unlike c-Kit positive CPCs, leukocytes cells also have CD45 and CD34 receptor. Flow cytometry was used to identify the purity of the CPCs. As shown in Fig. 1A , the percentage of c-Kit positive CPCs was~95.3%, while the percentage of CD45 and CD34 leukocytes cells was only~3.5% and 1.64%, respectively. We believe that the high ratio of c-Kit positive CPCs has met the requirements for our subsequent experiments.
To explore the role of hypoxia in the biological property of CPCs, CoCl 2 was used to create a hypoxia CPC model. Quantitative realtime RT-PCR analysis showed that CoCl 2 treatment significantly increased the expression of Hif-1α mRNA in a dose-dependent manner, which suggested that CoCl 2 -induced hypoxia CPC model was successfully constructed (Fig. 1B) . Furthermore, CoCl 2 stimuli decreased the CPC viability at high CoCl 2 concentration (Fig. 1C) . Meanwhile, EdU incorporation assay and cell migration assay illustrated that CoCl 2 -induced hypoxia inhibited the proliferation and migration potential of CPCs (Fig. 1D,E) .
H19 suppression induces CPC injury under hypoxia condition
H19 is involved in pathological cardiac remodeling process. We wondered whether H19 plays an important role in the proliferation and migration of CPCs. As shown in Fig. 2A , H19 expression was significantly decreased under 200 and 400 μM CoCl 2 treatment. To further determine whether H19 is involved in CoCl 2 -induced CPC injury, we analyzed the biological property of CPCs after H19 suppression. siRNAs specific to H19 were designed to repress the expression of H19 in CPCs (Fig. 2B) . H19 knockdown can deteriorate the cell viability under both normoxia and hypoxia conditions (Fig. 2C) . The proliferation and migration potential of CPCs were also inhibited after H19 suppression (Fig. 2D,E) . These data clearly indicated that knockdown of H19 could inhibit the proliferation and migration of CPCs, suggesting that H19 is important for the function of CPCs. 
MiR-200a-3p is crucial for regulating the proliferation and migration of CPCs
To further investigate the underlying mechanism of the H19 in CPCs under hypoxia, we performed bioinformatic analysis to screen the miRNAs targeted by H19. Online software starBase v2.0 was used for screening. It was found that miR-200a-3p is the target of H19. To explore the possible function of miR-200a-3p in the proliferation and migration of CPCs, quantitative real-time RT-PCR was performed to analyze the expression level of miR-200a-3p in CPCs after hypoxia stimuli. As shown in Fig. 3A, miR-200a-3p expression level was significantly increased after treatment with 200 and 400 μM CoCl 2 , but not after treatment with 100 μM CoCl 2 . Cell viability analysis and EdU incorporation assay illustrated that miR200a-3p mimics can reduce the viability and proliferation potential of CPCs (Fig. 3B,C) . In contrast, miR-200a-3p inhibitors significantly enhanced the viability and proliferation property of CPCs (Fig. 3B,C) . Meanwhile, the migration potential of CPCs was inhibited by miR-200a-3p mimics but promoted by miR-200a-3p inhibitors (Fig. 3D) . These data demonstrated that miR-200a-3p can affect the proliferation and migration of CPCs, indicating that miR200a-3p plays an important role in maintaining CPC function.
H19 regulates the proliferation and migration of CPCs through targeting miR-200a-3p in hypoxia
We further explored whether H19 regulates CPC function via miR200a-3p in response to hypoxia. Quantitative real-time RT-PCR results demonstrated that miR-200a-3p expression level was significantly elevated after downregulation of H19 expression in CPCs under both normoxia and hypoxia conditions (Fig. 4A) , suggesting that H19 can regulate miR-200a-3p expression in CPCs. In addition, dual-luciferase reporter assay was applied to investigate the intermolecular binding between H19 and miR-200a-3p. Wild-type H19 and miR-200a-3p mimics co-transfection in CPCs decreased the luciferase activity, while mutant H19 and miR-200a-3p mimics co-transfection partially restored the luciferase activity (Fig. 4B) . These results confirmed that miR-200a-3p was regulated by H19. We then further investigated whether H19-targeted miR-200a-3p contributes to proliferation inhibition of CPCs in response to hypoxia. Indeed, it was found that the reduced viability, proliferation, and migration potential of CPCs by H19 knockdown was significantly rescued by miR-200a-3p inhibitors under hypoxia (Fig. 4C-E) . These results confirmed that H19 can affect the proliferation and migration of CPCs under hypoxia condition through modulation of miR-200a-3p.
Sirt1 is involved in the CoCl 2 -induced CPC injury
miRNAs function by targeting mRNAs to regulate various biological processes, therefore bioinformatics analysis were applied to predict the potential target mRNAs of miR-200a-3p. Using the in silico miRNA target prediction tools PicTar and TargetScan, we found that Sirt1 mRNA could be a target of miR-200a-3p. Therefore, we explored whether miR-200a-3p targets Sirt1 and plays a role in hypoxia-induced CPC damage. Quantitative real-time RT-PCR and western blot analysis results illustrated that Sirt1 expression level was decreased in CPCs under 200 and 400 μM CoCl 2 treatment, but not under 100 μM CoCl 2 treatment (Fig. 5A) . Suppression of Sirt1 significantly repressed the viability, migration and proliferation potential of CPCs in hypoxia (Fig. 5B-D) . These data suggested that Sirt1 plays a role in CPC injury after hypoxia stimuli.
Sirt1 suppression antagonizes the protective effect of miR-200a-3p inhibitors on CPCs during hypoxia
The above data demonstrated that Sirt1 is involved in the function of CPCs under hypoxia, we thus explored whether the regulation of Sirt1 by miR-200a-3p is involved in hypoxia-induced CPC damage. As showed in Fig. 6A , both the mRNA and protein levels of Sirt1 were decreased in the miR-200a-3p mimics group, but were restored in the miR-200a-3p inhibitor group. Dual-luciferase reporter assay was further applied to demonstrate the binding of Sirt1 with miR200a-3p. The results shown in Fig. 6B indicated that miR-200a-3p mimics inhibited luciferase activity of the wild-type Sirt1 reporter, but no change was observed for the luciferase activity in the mutant reporter. These results suggested that Sirt1 is indeed regulated by miR-200a-3p in CPCs. We further investigated the regulation of Sirt1 by miR-200a-3p in hypoxia. Three kinds of siRNAs specific to Sirt1 were designed to suppress Sirt1 expression at both mRNA level and protein level (Fig. 6C) . Sirt1 knockdown inhibited the elevated viability, migration and proliferation of CPCs induced by miR200a-3p inhibitor under hypoxia, suggesting that Sirt1 suppression can block the cell protection effect induced by miR-200a-3p inhibitors (Fig. 6D-F) . These data indicated that miR-200a-3p exerts its findings, we thus hypothesized that H19 might regulate the proliferation and migration of CPCs through the H19/miR-200a-3p/Sirt1 axis signaling pathway. Indeed, both the mRNA level and protein level of Sirt1 were significantly repressed after H19 suppression under normoxia and hypoxia conditions (Fig. 7A) . Meanwhile, modulation of the H19/miR-200a-3p/Sirt1 axis affected the proliferation and migration of CPCs under hypoxia stress (Fig. 7B-D) .
Taken together, these results demonstrated that H19 indeed plays its 
Discussion
Recently, CPCs based therapy has become a promising method for heart repair after ischemia damage [8] [9] [10] [11] [12] . The advantage of CPC therapy is that CPCs are endogenous components of the adult heart and can regenerate new cardiac tissue through inducing angiogenesis and cardiogenesis without immunologic rejection [33] . However, poor proliferation and retention of CPCs in the infarcted myocardium in vivo or ex vivo is one of the primary barriers for the effectiveness of CPC therapy [13, 14] . New methods that can promote the proliferation of CPCs are crucial for enhancing regenerative potential during the heart repair process.
In mammals, oxygen (O 2 ) availability affects almost all biological processes, such as development, cell proliferation as well as differentiation [34] . We found that hypoxia can inhibit the CPC proliferation as well as migration (Fig. 1) , which is consistent with previous report that deficiency of oxygen resulted in decreased proliferation property of CPCs in infarcted myocardium.
More than 98% of the human genome was covered by noncoding RNAs (ncRNAs) [15] . The small ncRNAs, such as microRNAs, have been investigated for a long time. Emerging evidence suggests that lncRNAs play important roles in regulating the physiology and pathology of the cardiovascular system [21] [22] [23] [24] . It has been demonstrated that lncRNA-H19 is up-regulated in cardiac hypertrophy and HF by RNA-sequencing approach [30] . H19 was found to protect cardiomyocytes from phenylephrine-induced hypertrophy by targeting to CaMKII, a direct target of miR-675 [31] . Meanwhile, H19 can also inhibit cardiomyocyte necrosis in vitro after H 2 O 2 insult by regulating FADD through miR-103/107 [35] . These previous experiments suggested that H19 has a protective role in heart function. We wondered that whether H19 is related to CPC proliferation and plays a potential role in protecting heart after ischemia damage. We found that H19 was up-regulated in CPCs after CoCl 2 -induced hypoxia. Knockdown of H19 significantly decreased the proliferation and migration of CPCs, suggesting that H19 is a positive regulator in CPC proliferation.
Given that lncRNAs can alter the targeted microRNA to regulate many biological processes [36] , we performed bioinformatics analysis and found that miR-200a-3p is a target of H19. The miR200a-3p expression pattern was negatively correlated with the H19 level. Alterations in miR-200a-3p significantly affected the proliferation and migration potential of CPCs, suggesting that miR-200a-3p is indeed a downstream target of H19.
Further bioinformatics analysis identified that Sirt1 is a target of miR-200a-3p. MiR-200a-3p mimics decreased Sirt1 expression, while miR-200a-3p inhibitors increased the Sirt1 expression. As an important deacetylase, Sirt1 regulates a variety of biological processes [37] . Sirt1 was reported to play important roles in heart function. Inhibition of Sirt1 activity can increase the rate of cardiomyocyte death [38] . In our study, we found that knockdown of Sirt1 significantly reduced the proliferation and migration of CPCs. We further found that Sirt1 expression was positively correlated with H19 but negatively correlated with miR-200a-3p, suggesting that the H19/ miR-200a-3p/Sirt1 signaling axis indeed exists in CPCs.
In summary, our findings demonstrated that the H19/miR-200a-3p/Sirt1 is a novel regulatory mechanism for promoting CPC proliferation and migration, which may provide a novel therapeutic approach for myocardium repair after heart ischemia injury.
